08 Nov 2023

“I learned to be positive”: Lizzi’s AML story

“The first thing that happened about nine months before my diagnosis is I went off drinking tea which I normally love,” said Lizzi Wright, 64. “Then I started losing weight at about the rate of 4lbs a week. I visited the doctor every two weeks. They told me I was just run down and depressed.  

“Then in February 2013 I developed an infected finger that went almost black. The nurse said it was a whitlow and dressed it. But over the next two weeks in the left corner of my mouth I developed a big black sore, and also ulcers in my mouth which were horrifically painful.  

“By that time I had lost nearly five stone. I kept phoning the doctors and asking for a blood test but it never happened. By this time I was too tired to care. My husband Alan and my family were worried.  

“On March 31st I asked the receptionist at the doctor to let me have a blood test. They gave me an appointment for 9am on 4th April. At 4.30 pm the surgery rang to tell me that a bed was ready for me in Manchester Royal Hospital on Ward 44 – the haematology ward.” 

Lizzi was diagnosed with acute myeloid leukaemia (AML) that evening, and treatment was started immediately.  

“I got there at 6pm and was given a vitamin K syringe straight away which was fantastic. It cured my finger and mouth sore in days. After three days with further tests, my consultant spoke with me and my husband and told us if I had chemotherapy I had a 70% chance of surviving. If not I had just three weeks left. Of course I chose the chemo.” 

Lizzi had four rounds of chemotherapy and was in hospital for four months.  

“The main side effect was diarrhoea. But my weight started to come back. My hair was shaved off which was a relief because holding your hair in your hands whilst washing it is so scary. By the end of April I was in remission. 

“Once I finished the initial treatment I went once a month for tests for a year, then it was every three months for two years, then another two years every six months. Now I just have full blood counts done at the doctor once a year. My Hickman line stayed in for two years. The worst part of it all was the boredom and letting my mind overthink. But I learnt to be positive and make plans for the future. 

“I call Manchester Royal a place of angels. They were fantastic. The impact at first on my family was tears and fears of course. But we are now even closer than ever this last 10 years and we all love life together. My journey is to keep well. No stress because all cancers love stressed bodies. Enjoy life.” 

Read more stories from people affected by leukaemia.

Related posts

Why I became a Leukaemia UK Trustee

11 February 2021

Why I became a Leukaemia UK Trustee

Caroline Evans – Leukaemia UK Trustee and Projects Consultant – reflects on why she became a Trustee and what drives her in the role.

MP opens Leukaemia UK Ambulatory Care Unit

15 June 2018

MP opens Leukaemia UK Ambulatory Care Unit

A unit funded by Leukaemia UK which allows people with blood cancer to have stem cell transplants as out-patients has been officially opened by its first patient, Nick Boles MP

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

8 September 2022

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement: “We are extremely saddened to hear the news of the death of…

An urgent call from One Cancer Voice group of cancer charities for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival & care

10 November 2021

An urgent call from One Cancer Voice group of cancer charities for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival & care

Leukaemia UK has joined with 50 other cancer charities in writing to the Prime Minister, Chancellor of the Exchequer and Secretary of State for Health and Social Care. We are calling on the Government to urgently deliver on commitments to improve cancer survival and care in the forthcoming Spending Review.